Document Detail


Efficacy and safety of pitavastatin in Japanese patients with hypercholesterolemia: LIVES study and subanalysis.
MedLine Citation:
PMID:  21615316     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
The Livalo Effectiveness and Safety (LIVES) study was an observational study to examine the efficacy and safety of pitavastatin, a newly developed drug, in approximately 20,000 Japanese patients with hypercholesterolemia. During a 2-year follow-up period, no significant problems concerning safety were observed upon treatment with pitavastatin. Pitavastatin demonstrated potent and stable lowering of the LDL-cholesterol level. The LIVES study subanalyses revealed significant and continuous elevation of HDL-cholesterol in association with pitavastatin treatment and also showed that the drug did not adversely affect glycemic control as evaluated by the glycohemoglobin A(1c) level. Moreover, pitavastatin treatment was associated with an increase in estimated glomerular filtration rate in subjects with chronic kidney disease. These results suggest the usefulness of pitavastatin in hypercholesterolemic patients from various backgrounds. The ongoing LIVES study extension is expected to provide further data on cardiovascular outcome in subjects treated with pitavastatin.
Authors:
Koutaro Yokote; Hitoshi Shimano; Mitsuyoshi Urashima; Tamio Teramoto
Related Documents :
2403226 - Nasal physiology and inflammatory mediators during natural pollen exposure.
11284796 - Three years of specific immunotherapy with house-dust-mite extracts in patients with rh...
12590876 - Nasal immunotherapy is effective in the treatment of rhinitis due to mite allergy. a do...
8328656 - Effects of h1-receptor antagonists on nasal obstruction in atopic patients.
10327916 - Prefrontal cortical dysfunction in depression determined by wisconsin card sorting test...
20948896 - Effect of yoga on quality of life of clbp patients: a randomized control study.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Expert review of cardiovascular therapy     Volume:  9     ISSN:  1744-8344     ISO Abbreviation:  Expert Rev Cardiovasc Ther     Publication Date:  2011 May 
Date Detail:
Created Date:  2011-05-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101182328     Medline TA:  Expert Rev Cardiovasc Ther     Country:  England    
Other Details:
Languages:  eng     Pagination:  555-62     Citation Subset:  IM    
Affiliation:
Department of Clinical Cell Biology and Medicine, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan. kyokote@faculty.chiba-u.jp.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Prognosis and Prognostic Factors for Distant Metastases and Tumor Mortality in Follicular Thyroid Ca...
Next Document:  Does remote ischemic conditioning salvage left ventricular function after successful primary PCI?